Document Type : Research articles


1 Department of Anesthesiology, First affiliated hospital of Nanchang University, Nanchang, Jiangxi, 330031, China

2 Medicine Graduate School, Nanchang University, Nanchang, Jiangxi, 330031, China

3 Department of Anesthesiology, First Affiliated Hospital of Nanchang University


Background: Burns are among the most life-threatening forms of trauma requiring timely and effective treatment.
Objectives: The present study aimed to assess the inhibitory effect of remifentanil on the stress response of burn patients undergoing escharectomy and skin grafting.
Methods: A total of 52 patients undergoing burn scab removal surgery were selected and randomly assigned to two groups: remifentanil group (group R) and fentanyl (group F). Anesthesia induction: Group R was administered an intravenous injection of propofol, rocuronium, and remifentanil, while Group F received an intravenous injection of propofol, rocuronium, and fentanyl. After tracheal intubation, group R was injected intravenously with remifentanil and propofol to maintain anesthesia. Group F was induced with fentanyl. Thereafter, the patient's blood pressure and heart rate (HR) were recorded. Subsequently, their carotid artery blood was withdrawn, and they were tested for epinephrine (E), norepinephrine (NE), and blood glucose. Finally, the patients' eye-opening time and extubation time at the end of anesthesia were recorded.
Results: After anesthesia induction, the mean artery pressure, HR, and E in group R were lower than those in group F. There was no statistically significant difference between the levels of NE in the two groups. Nonetheless, the eye-opening time and extubation time in group R were significantly shorter than those in group F.
Conclusion: Compared to fentanyl, remifentanil can more effectively reduce the stress response of surgery and anesthesia. It can integrate anesthetic drugs with blood pressure control. Furthermore, this method is simple, effective, safe, and reliable.


  1. Arturson G. Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995. Burns. 1996;22(4):255-74. doi: 10.1016/0305-4179(95)00153-0. [PubMed: 8781717].
  2. Wilmore DW. Pathophysiology of the hypermetabolic response to burn injury. J Trauma. 1990;30(12):S4-6. doi: 10.1097/00005373-199012001-00003. [PubMed: 2254989].
  3. Cancio LC, Cuenca PB, Walker SC, Shepherd JM. Total intravenous anesthesia for major burn surgery. Int J Burns Trauma. 2013;3(2):108-14. [PubMed: 23638329].
  4. Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109-17. doi: 10.1093/bja/85.1.109. [PubMed: 10927999].
  5. Pereira C, Murphy K, Jeschke M, Herndon DN. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol. 2005;37(10):1948-61. doi: 10.1016/j.biocel.2005.05.009. [PubMed: 16109499].
  6. Beers R, Camporesi E. Remifentanil update: clinical science and utility. CNS Drugs. 2004;18(15):1085-104. doi: 10.2165/00023210-200418150-00004. [PubMed: 15581380].
  7. Porter C, Tompkins RG, Finnerty CC, Sidossis LS, Suman OE, Herndon DN. The metabolic stress response to burn trauma: current understanding and therapies. Lancet. 2016;388(10052):1417-26. doi: 10.1016/S0140-6736(16)31469-6. [PubMed: 27707498].
  8. Zhou B, Te Ba, Wang L, Gao Y, He Q, Yan Z, Wang H, Shen G. Combination of sodium butyrate and probiotics ameliorates severe burn-induced intestinal injury by inhibiting oxidative stress and inflammatory response. Burns. 2022;48(5):1213-20. doi: 10.1016/j.burns.2021.11.009. [PubMed: 34903409].
  9. Myre K, Raeder J, Rostrup M, Buanes T, Stokland O. Catecholamine release during laparoscopic fundoplication with high and low doses of remifentanil. Acta Anaesthesiol Scand. 2003;47(3):267-73. doi: 10.1034/j.1399-6576.2003.00073.x. [PubMed: 12648191].
  10. Kovac AL, Azad SS, Steer P, Witkowski T, Batenhorst R, McNeal S. Remifentanil versus alfentanil in a balanced anesthetic technique for total abdominal hysterectomy. J Clin Anesth. 1997;9(7):532-41. doi: 10.1016/s0952-8180(97)00140-2. [PubMed: 9347428].
  11. Twersky RS, Jamerson B, Warner DS, Fleisher LA, Hogue S. Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth. 2001;13(6):407-16. doi: 10.1016/s0952-8180(01)00292-6. [PubMed: 11578883].
  12. Kawano H, Manabe S, Matsumoto T, Hamaguchi E, Kinoshita M, Tada F, Oshita S. Comparison of intraoperative blood loss during spinal surgery using either remifentanil or fentanyl as an adjuvant to general anesthesia. BMC Anesthesiol. 2013;13(1):46. doi: 10.1186/1471-2253-13-46. [PubMed: 24304964].
  13. Azemati S, Savai M, Khosravi MB, Allahyari E, Jahanmiri F. Combination of remifentanil with isoflurane or propofol: effect on the surgical stress response. Acta Anaesthesiol Belg. 2013;64(1):25-31. [PubMed: 23767174].
  14. Hu LG, Pan JH, Li J, Kang F, Jiang L. Effects of different doses of sufentanil and remifentanil combined with propofol in target-controlled infusion on stress reaction in elderly patients. Exp Ther Med. 2013;5(3):807-12. doi: 10.3892/etm.2013.900. [PubMed: 23407772].
  15. Pandya AN, Majid SZ, Desai MS. The Origins, Evolution, and Spread of Anesthesia Monitoring Standards: From Boston to Across the World. Anesth Analg. 2021;132(3):890-98. doi: 10.1213/ANE.0000000000005021. [PubMed: 32665466].
  16. Norbury WB, Herndon DN, Branski LK, Chinkes DL, Jeschke MG. Urinary cortisol and catecholamine excretion after burn injury in children. J Clin Endocrinol Metab. 2008;93(4):1270-5. doi: 10.1210/jc.2006-2158. [PubMed: 18211976].
  17. Przkora R, Barrow RE, Jeschke MG, Suman OE, Celis M, Sanford AP, et al. Body composition changes with time in pediatric burn patients. J Trauma. 2006;60(5):968-71. doi: 10.1097/
  18. ta.0000214580.27501.19. [PubMed: 16688056].
  19. Kazmaier S, Hanekop GG, Buhre W, Weyland A, Busch T, Radke OC, et al. Myocardial consequences of remifentanil in patients with coronary artery disease. Br J Anaesth. 2000;84(5):578-83. doi: 10.1093/bja/84.5.578. [PubMed: 10844832].
  20. Winterhalter M, Brandl K, Rahe-Meyer N, Osthaus A, Hecker H, Hagl C, et al. Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl. Eur J Anaesthesiol. 2008;25(4):326-35. doi: 10.1017/S0265021507003043. [PubMed: 18005471].
  21. Bache S, Stendell L, Olsen NV, Olsen KS. Problems in obtaining sufficient anaesthesia with propofol and remifentanil: three cases, a test infusion, and a review. Br J Anaesth. 2013;110(5):741-6. doi: 10.1093/bja/aes474. [PubMed: 23257992].
  22. Choi JW, Joo JD, Kim DW, In JH, Kwon SY, Seo K, et al. Comparison of an Intraoperative Infusion of Dexmedetomidine, Fentanyl, and Remifentanil on Perioperative Hemodynamics, Sedation Quality, and Postoperative Pain Control. J Korean Med Sci. 2016;
  23. (9):1485-90. doi: 10.3346/jkms.2016.31.9.1485. [PubMed: 27
  24. .
  25. Guo Z, Pang L, Jia X, Wang X, Su X, Li P, Mi W, Hao J. Intraoperative target-controlled infusion anesthesia application using remifentanil hydrochloride with etomidate in patients with severe burn as monitored using Narcotrend. Burns. 2015;41(1):100-5. doi: 10.1016/j.burns.2014.04.021. [PubMed: 24931823].
  26. Ince IE, Iyilikci L, Yilmaz S, Güneş D, Akkuş M, Isguven D. Sedation for short hemato-oncologic invasive procedures in children: comparison of propofol-remifentanil and propofol-fentanyl. J Pediatr Hematol Oncol. 2013;35(2):112-7. doi: 10.1097/MPH.0b013e318279cbda. [PubMed: 23412587].
  27. Wojciechowski P, Kleczkowska P, Mollica A, Stefanucci A, Kaczyńska K. Vagal apnea and hypotension evoked by systemic injection of an antinociceptive analogue of endomorphin-2. Eur J Pharmacol. 2020;885:173514. doi: 10.1016/j.ejphar.2020.
  28. [PubMed: 32860810].
  29. Farias M, Jackson K, Yoshishige D, Caffrey JL. Bimodal delta-opioid receptors regulate vagal bradycardia in canine sinoatrial node. Am J Physiol Heart Circ Physiol. 2003;
  30. (3):H1332-9. doi: 10.1152/ajpheart.00353.2003. [Pub
  31. Med: 12915393].
  32. Wong GT, Huang Z, Ji S, Irwin MG. Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth. 2010;24(5):790-6. doi: 10.1053/
  33. j.jvca.2009.09.012. [PubMed: 20056436].